CDK7 and esophageal squamous cell carcinoma: In conclusion, we demonstrated that SNS-032, as a potent and selective CDK7/9 inhibitor, which leads to inhibition of transcription initiation and elongation, effectively inhibited cell growth and induced apoptosis in ESCC cells.